Tagamet

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1976-2015
051019762015

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
BACKGROUND The extension of biowaivers (drug product approval without a pharmacokinetic bioequivalence study) to drugs belonging… (More)
Is this relevant?
2000
2000
Cimetidine (Tagamet) is a potent histaminic H2-receptor antagonist, extensively prescribed for ulcers and now available without… (More)
Is this relevant?
1999
1999
PURPOSE To report the efficacy of cimetidine for treatment of conjunctival papillomatosis. METHODS An 11-year-old boy had an 8… (More)
Is this relevant?
1997
1997
Lifestyle, sexual history, and medical history characteristics were analyzed as risk factors for non-Hodgkin's lymphoma (NHL) in… (More)
Is this relevant?
1987
1987
A 20-year-old woman presented with an apparent acute dystonic reaction after only five doses of cimetidine (Tagamet). The patient… (More)
Is this relevant?
1984
1984
We acknowledge the valuable support rendered by the Smith, Kline and French medical department. 
Is this relevant?
1983
1983
One hundred twenty-six parturients for elective cesarean section under general anesthesia were allocated to either a cimetidine… (More)
Is this relevant?
1980
1980
Cimetidine has been administered during 7 days to 28 patients with different degrees of renal failure. Thirteen of these patients… (More)
Is this relevant?
1979
1979
The results from the treatment of 25 patients with duodenal ulcer with 1 g tagamet daily (3x200 mg after meal and 400 mg in the… (More)
Is this relevant?
1977
1977
Cimetidine, a potent H2-receptor antagonist, has been introduced for the treatment of various conditions associated with acid… (More)
Is this relevant?